← Scroll for more →
Financial Statements — NNE
Balance Sheet
(in millions USD)| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 298.47 | 197.68 | 577.53 | 203.27 | 210.18 | 118.55 | 123.27 | -- | -- | -- |
| Short-term Investments | 281.52 | 371.00 | 0.28 | -- | -- | -- | -- | -- | -- | -- |
| Accounts Receivable | 0.29 | 0.25 | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | 585.29 | 571.70 | 580.76 | 204.67 | 212.20 | 119.47 | 128.45 | 29.34 | 14.32 | 6.59 |
| Property, Plant & Equipment | 18.98 | 18.09 | 11.03 | 9.78 | 5.34 | 5.28 | 1.67 | 1.69 | -- | -- |
| Goodwill | 4.24 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets | 5.55 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-current Assets* | 42.74 | 32.22 | 25.29 | 23.99 | 19.33 | 19.34 | 5.69 | 5.75 | 2.11 | 2.28 |
| Total Assets | 628.03 | 603.92 | 606.06 | 228.66 | 231.53 | 138.82 | 134.14 | 35.10 | 16.43 | 8.87 |
| Accounts Payable | 4.71 | 4.35 | 2.54 | 1.31 | 0.60 | 2.54 | 0.90 | 0.76 | 0.23 | 0.30 |
| Total Current Liabilities | 7.39 | 5.97 | 4.33 | 3.83 | 2.91 | 4.39 | 2.52 | 1.84 | 1.81 | 0.61 |
| Total Non-current Liabilities* | 4.61 | 2.05 | 2.15 | 2.26 | 2.31 | 2.40 | 1.57 | 1.65 | 1.62 | 1.63 |
| Total Liabilities | 12.00 | 8.03 | 6.48 | 6.09 | 5.22 | 6.79 | 4.09 | 3.49 | 3.42 | 2.23 |
| Retained Earnings | (83.30) | (73.20) | (64.02) | (57.50) | (49.45) | (41.86) | (20.55) | (17.43) | (14.94) | (10.27) |
| Total Stockholder Equity | 616.03 | 595.89 | 599.58 | 222.57 | 226.31 | 132.03 | 130.06 | 31.61 | 13.00 | 6.64 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.21 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cost of Revenue | 0.15 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | 0.06 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | 3.99 | 5.66 | 5.40 | 4.16 | 3.67 | 6.71 | 0.90 | 0.90 | 2.02 | 0.29 |
| Selling, General & Admin | 11.86 | 8.59 | 6.89 | 6.05 | 5.32 | 15.70 | 2.49 | 2.30 | 2.30 | 1.42 |
| Total Operating Expenses | 15.89 | 14.07 | 11.56 | 10.41 | 9.39 | 22.49 | 3.92 | 2.74 | 4.71 | 1.71 |
| Operating Income | (15.83) | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income | (10.10) | (9.18) | (6.52) | (8.05) | (7.59) | (21.31) | (3.11) | (2.49) | (4.67) | (1.68) |
| Basic EPS | (0.19) | (0.18) | (0.13) | (0.21) | (0.19) | (0.57) | (0.09) | (0.08) | (0.17) | (0.07) |
| Diluted EPS | (0.19) | (0.18) | (0.13) | (0.21) | (0.19) | (0.57) | (0.09) | (0.08) | (0.17) | (0.07) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (9.41) | (5.26) | (3.99) | (4.91) | (9.09) | (2.38) | (3.24) | (2.51) | (2.54) | (3.41) |
| Capital Expenditures | 1.07 | 8.76 | -- | 4.65 | 0.18 | 3.63 | -- | -- | -- | -- |
| Free Cash Flow* | (10.48) | (14.02) | -- | (9.56) | (9.27) | (6.00) | -- | -- | -- | -- |
| Investing Cash Flow | 82.88 | (377.44) | (3.06) | (4.65) | (0.18) | (9.14) | (3.56) | -- | -- | -- |
| Financing Cash Flow | 27.32 | 2.85 | 381.33 | 2.64 | 100.90 | 6.80 | 101.56 | 20.93 | 10.38 | 2.41 |
← Scroll for more columns →
* Derived from reported values